2m 2m 2m 2m 2m 2m 2m
STEREOTAXIS (STXS)
NYSE
$1.75-$0.12 (-6.42%)
Price as of Jun 23, 2026 4:38 PM EDT- $182.8MMarket Cap
- -11.37%1-Year Change
- Medical Instruments & SuppliesIndustry
STEREOTAXIS (STXS)
$1.75-$0.12 (-6.42%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 10.2M -62.02% | 26.9M +0.55% | 26.8M -4.89% | 28.1M -19.63% | |
Cost of Revenue | 8.0M -34.86% | 12.3M +3.47% | 11.9M +23.09% | 9.7M -17.92% | |
Gross Profit | 17.1M +16.97% | 14.6M -1.79% | 14.9M -19.55% | 18.5M -20.50% | |
Sales and Marketing Expense | 12.4M +0.57% | 12.4M -0.03% | 12.4M +0.41% | 12.3M +3.15% | |
Research and Development Expense | -9.4M -3.86% | -9.8M -4.99% | -10.3M -197.30% | 10.6M +3.52% | |
Depreciation and Amortization Expense | 929,000 +58.26% | 587,000 -1.34% | 595,000 +38.69% | 429,000 +306.05% | |
Total Operating Expenses | 39.2M -0.38% | 39.3M +7.18% | 36.7M -1.47% | 37.2M +3.12% | |
Operating Profit | -22.1M -10.62% | -24.7M +13.28% | -21.8M +16.31% | -18.8M +45.68% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 0 N/A | 0 N/A | 0 -100.00% | 484,000 +4,905.88% | |
Total Nonoperating Income and Expense | 2,000 -99.71% | 694,000 -36.68% | 1.1M +126.45% | 484,000 +4,905.88% | |
Income before Taxes | -22.9M -9.62% | -25.4M +14.95% | -22.1M +12.33% | -19.6M +62.80% | |
Income Taxes | 2.2M -0.05% | 2.2M -23.67% | 2.9M +38.31% | 2.1M +20.97% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -22.9M -4.70% | -24.0M +16.09% | -20.7M +13.24% | -18.3M +70.70% | |
Net Income from Continuing Operations Applicable to Common | -22.9M -9.62% | -25.4M +14.95% | -22.1M +12.33% | -19.6M +62.80% | |
Basic EPS and Net Income | -0.25 -16.67% | -0.30 +11.11% | -0.27 +3.85% | -0.26 +62.50% | |
Diluted EPS and Net Income | -0.25 -16.67% | -0.30 +11.11% | -0.27 +3.85% | -0.26 +62.50% | |
Basic Weighted Average Shares | 91.0M +6.78% | 85.2M +5.55% | 80.7M +6.10% | 76.1M +0.67% | |
Diluted Weighted Average Shares | 91.0M +6.78% | 85.2M +5.55% | 80.7M +6.10% | 76.1M +0.67% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 13.4M +9.86% | 12.2M -38.35% | 19.8M +130.82% | 8.6M -77.84% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | 19.8M N/A | |
Cash and Cash Equivalents and Short-Term Investments | 13.4M +9.86% | 12.2M -38.35% | 19.8M -30.29% | 28.4M -26.61% | |
Total Current Assets | 33.8M +28.03% | 26.4M -20.52% | 33.3M -23.07% | 43.2M -15.84% | |
Accumulated Depreciation | 4.8M +8.44% | 4.4M +14.58% | 3.9M +12.09% | 3.5M +7.67% | |
Property and Plant and Equipment and Net | 3.0M -15.51% | 3.6M +8.14% | 3.3M -13.76% | 3.8M +45.56% | |
Total Long-Term Assets | 3.0M -15.51% | 3.6M +8.14% | 3.3M -13.76% | 3.8M +1,277.29% | |
Total Assets | 52.3M +11.83% | 46.7M +11.49% | 41.9M -21.54% | 53.4M -12.42% | |
Income Taxes Payable | 3.2M +7.97% | 3.0M -0.96% | 3.0M -11.43% | 3.4M +16.41% | |
Total Short-Term Debt | 1.8M 0.00% | 1.8M 0.00% | 1.8M -14.29% | 2.1M +200.00% | |
Total Current Liabilities | 22.4M +3.51% | 21.6M +63.07% | 13.2M -7.31% | 14.3M +7.76% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 1.1M +1,614.06% | 64,000 +48.84% | 43,000 -15.69% | 51,000 -76.67% | |
Total Liabilities | 33.5M -4.99% | 35.3M +76.56% | 20.0M -6.96% | 21.5M -0.36% | |
Retained Earnings | -583.4M +3.85% | -561.7M +4.47% | -537.7M +4.01% | -517.0M +3.67% | |
Total Stockholders Equity | 13.5M +121.73% | 6.1M -62.80% | 16.3M -37.97% | 26.3M -22.15% | |
Total Shares Outstanding | 95.3M +11.73% | 85.3M +5.41% | 80.9M +8.11% | 74.9M +0.34% | |
Cash Flow | |||||
Cash from Operating Activities | -13.7M +61.06% | -8.5M -7.02% | -9.1M +8.60% | -8.4M +185.65% | |
Capital Expenditures | 93,000 +173.53% | 34,000 -90.71% | 366,000 -84.61% | 2.4M +70.27% | |
Cash from Investing Activities | -93,000 -225.68% | 74,000 -99.63% | 19.8M +189.46% | -22.1M +1,482.00% | |
Dividends Paid | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Cash from Financing Activities | 14.8M +4,870.71% | 297,000 +266.67% | 81,000 -63.18% | 220,000 -59.81% | |
Financials Ratio | |||||
Gross Margin | 21.47% -60.40% | 54.22% -2.33% | 55.51% -15.41% | 65.62% -1.08% | |
Operating Margin | -216.30% +135.35% | -91.90% +12.66% | -81.58% +22.29% | -66.71% +81.26% | |
Return on Assets | -46.30% -14.66% | -54.26% +24.85% | -43.46% +35.90% | -31.98% +73.75% | |
Return on Equity | -234.28% +9.24% | -214.47% +121.01% | -97.04% +59.65% | -60.78% +94.18% | |
Revenue Growth | -62.02% -11,395.16% | 0.55% +111.23% | -4.89% -75.09% | -19.63% -162.29% | |
Current Ratio | 1.51 +23.69% | 1.22 -51.26% | 2.51 -17.01% | 3.03 -21.91% | |
Cash Ratio | 0.60 +6.14% | 0.57 -62.20% | 1.50 +149.00% | 0.60 -79.43% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow